Showing results (121-130 of 148) with videos related to
Sort By:
Pageof 15
Blood|February 27, 2008
The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemiaPieter Van Vlierberghe, Martine van Grotel, Joëlle Tchinda, et al.Nature Communications|June 13, 2019
Translatome analysis reveals altered serine and glycine metabolism in T-cell acute lymphoblastic leukemia cellsKim R Kampen, Laura Fancello, Tiziana Girardi, et al.Blood|February 18, 2014
G-749, a novel FLT3 kinase inhibitor, can overcome drug resistance for the treatment of acute myeloid leukemiaHee Kyu Lee, Hong Woo Kim, In Yong Lee, et al.Cancer Discovery|March 3, 2018
HOXA9 Cooperates with Activated JAK/STAT Signaling to Drive Leukemia DevelopmentCharles E de Bock, Sofie Demeyer, Sandrine Degryse, et al.Leukemia|June 23, 2018
The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALLKim R Kampen, Sergey O Sulima, Benno Verbelen, et al.Blood|September 30, 2008
Antileukemic effects of the novel, mutant FLT3 inhibitor NVP-AST487: effects on PKC412-sensitive and -resistant FLT3-expressing cellsEllen Weisberg, Johannes Roesel, Guido Bold, et al.Haematologica|May 7, 2016
RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implicationsValentina Gianfelici, Sabina Chiaretti, Sofie Demeyer, et al.Leukemia|March 10, 2019
Correction: The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALLKim R Kampen, Sergey O Sulima, Benno Verbelen, et al.Blood|October 11, 2014
ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemiaSofie Peirs, Filip Matthijssens, Steven Goossens, et al.Blood|February 24, 2019
Fratricide-resistant CD1a-specific CAR T cells for the treatment of cortical T-cell acute lymphoblastic leukemiaDiego Sánchez-Martínez, Matteo L Baroni, Francisco Gutierrez-Agüera, et al.Pageof 15